Brief: Barda Partners With Icon To Execute Next Generation Covid-19 Vaccines Clinical Trial
ICON PLC ICLR.O :
* BARDA PARTNERS WITH ICON TO EXECUTE NEXT GENERATION
COVID-19
VACCINES CLINICAL TRIAL
* ICON PLC - TRIAL WILL INVOLVE 10,000 SUBJECTS, EXPECTED TO
BE
ENROLLED OVER A SIX-MONTH PERIOD
* ICON PLC - BARDA WILL SELECT VACCINE CANDIDATE TO BE
INVESTIGATED IN THIS TRIAL
Source text for Eikon: ID:nBw7zS9cca
Further company coverage: ICLR.O
Recent news on Icon
See all newsIcon Plc Reports Results For The Quarter Ended September 30: Earnings Summary
Icon jumps after third-quarter profit beat
ICON's Q3 adj EPS and adj EBITDA beat analyst expectations
Icon Plc Expected To Post Earnings Of $2.60 A Share: Earnings Preview
Icon Plc Reports Results For The Quarter Ended June 30: Earnings Summary